JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

Search

Phreesia Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

13.14 -2.23

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

13.04

Max

13.68

Pagrindiniai rodikliai

By Trading Economics

Pajamos

3.6M

4.3M

Pardavimai

3.1M

120M

Pelno marža

3.549

Darbuotojai

2,082

EBITDA

6.1M

13M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+116.68% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-03-11

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-258M

948M

Ankstesnė atidarymo kaina

15.37

Ankstesnė uždarymo kaina

13.14

Naujienos nuotaikos

By Acuity

50%

50%

147 / 352 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

Phreesia Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-02 23:52; UTC

Įsigijimai, susijungimai, perėmimai

Elliott Management Doesn't Plan to Tender Its Shares at the Current Terms

2026-02-02 23:52; UTC

Įsigijimai, susijungimai, perėmimai

Elliott Management: Toyota Fudosan Revised Tender Offer for Toyota Industries 'Very Significantly Undervalues' Company

2026-02-02 23:48; UTC

Rinkos pokalbiai

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

2026-02-02 23:38; UTC

Rinkos pokalbiai

Gold Rises on Likely Technical Recovery, Dip-Buying Interest -- Market Talk

2026-02-02 23:28; UTC

Rinkos pokalbiai

SpaceX, xAI Deal Further Consolidates Musk's Businesses -- Market Talk

2026-02-02 23:23; UTC

Uždarbis

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- 2nd Update

2026-02-02 22:57; UTC

Uždarbis

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2026-02-02 22:22; UTC

Įsigijimai, susijungimai, perėmimai

What the Blockbuster SpaceX--xAI Merger Can Mean for Tesla Stock -- Barrons.com

2026-02-02 22:08; UTC

Rinkos pokalbiai

Australian Inflation Woes Rooted In Excess Govt Spending -- Market Talk

2026-02-02 21:51; UTC

Uždarbis

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2026-02-02 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-02 21:49; UTC

Uždarbis

Disney's Streaming Profit Surges as CEO Decision Approaches -- 5th Update

2026-02-02 21:39; UTC

Uždarbis

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2026-02-02 21:36; UTC

Uždarbis

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- Update

2026-02-02 21:34; UTC

Uždarbis

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2026-02-02 21:28; UTC

Įsigijimai, susijungimai, perėmimai

What a SpaceX--xAI Merger Could Mean for Tesla Stock -- Barrons.com

2026-02-02 21:23; UTC

Uždarbis

BYD, Chinese EV Stock Plunge On Weak Data. What That Means for Tesla Stock. -- Barrons.com

2026-02-02 21:19; UTC

Uždarbis

Palantir Technologies: U.S. Commercial Business Growing at 'Astonishing' Rate, Generating $507 Million Last Quarter, 137% Increase Over the Same Period the Year Before >PLTR

2026-02-02 21:17; UTC

Uždarbis

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- WSJ

2026-02-02 21:17; UTC

Uždarbis

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2026-02-02 21:10; UTC

Uždarbis

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2026-02-02 21:08; UTC

Uždarbis

Palantir Technologies: Rule of 40 Score Is Now 127% >PLTR

2026-02-02 21:07; UTC

Uždarbis

Palantir Technologies: Sees 2026 U.S. Comml Rev in Excess of $3.144B, Representing Growth Rate of at Least 115% >PLTR

2026-02-02 21:05; UTC

Uždarbis

Palantir Technologies 4Q Net $608.7M >PLTR

2026-02-02 21:05; UTC

Uždarbis

Palantir Technologies 4Q Rev $1.41B >PLTR

2026-02-02 21:05; UTC

Uždarbis

Palantir Technologies Sees 1Q Rev $1.53B-$1.54B >PLTR

2026-02-02 21:05; UTC

Uždarbis

Palantir Technologies Sees FY Rev $7.18B-$7.2B >PLTR

2026-02-02 21:05; UTC

Uždarbis

Palantir Technologies 4Q Adj EPS 25c >PLTR

2026-02-02 21:05; UTC

Uždarbis

Palantir Technologies 4Q EPS 24c >PLTR

2026-02-02 20:40; UTC

Rinkos pokalbiai

Treasury Yields, Dollar Rise Amid Signs of Resilient U.S. Economy -- Market Talk

Akcijų palyginimas

Kainos pokytis

Phreesia Inc Prognozė

Kainos tikslas

By TipRanks

116.68% į viršų

12 mėnesių prognozė

Vidutinis 29.1 USD  116.68%

Aukščiausias 35 USD

Žemiausias 24 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Phreesia Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

12 ratings

12

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

25.23 / 25.61Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Neutral Evidence

Vidutinės trukmės periodas

Strong Bullish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

147 / 352 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
help-icon Live chat